Christopher Schroeder

7PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 09, 2026
Genetic landscape of stage II melanoma identifies CBL as a new driver gene and prognostic biomarker.

Elena Sophia Lindner, Jakob Admard, German Demidov

|Oct 31, 2025
Multi-modal omics analysis of a paediatric melanoma highlights mechanisms underlying treatment resistance.

Marlena Mucha, Sebastian Bühner, Maurice Loßner

|Oct 09, 2024
Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibition.

Christopher Schroeder, Sergios Gatidis, Olga Kelemen

|Oct 20, 2023
Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients.

Michael Menzel, Stephan Ossowski, Sebastian Kral

|Jul 28, 2023
Clinical trio genome sequencing facilitates the interpretation of variants in cancer predisposition genes in paediatric tumour patients.

Christopher Schroeder, Ulrike Faust, Luisa Krauße

Pageof 2